AstraZeneca aims to offset drug setback at big cancer congress Ruby Khatun Khatun2 Sept 2017 9:30 AM ISTLONDON: After last month’s big clinical trial setback in lung cancer, AstraZeneca will seek to rebuild its oncology reputation next week when it...
Arrow Pharma acquires Australian operations of Amneal Pharma Ruby Khatun Khatun1 Sept 2017 1:38 PM ISTNew Delhi: Drug firm Strides Shasun said its arm Arrow Pharmaceuticals has acquired Australian operations of Amneal Pharmaceuticals for a total...
Dr Reddys settles patent row with Vivus on weight management drug Ruby Khatun Khatun1 Sept 2017 1:29 PM ISTHyderabad: Nasdaq-listed Vivus Inc on Thursday entered into a settlement agreement with Dr Reddy's Laboratories to resolve a long-pending patent...
Panacea Biotech promoters may demerge real estate business into separate firm Ruby Khatun Khatun1 Sept 2017 1:29 PM ISTNew Delhi: Drug firm Panacea Biotec on Wednesday said its promoters have entered into a family agreement under which they plan to demerge the...
AstraZeneca taps AI for drug discovery in deal with Berg Ruby Khatun Khatun1 Sept 2017 9:45 AM ISTLONDON: AstraZeneca has forged a research collaboration with Boston-based Berg, a specialist in artificial intelligence for drug hunting, in the...
Advertising budget for Obamacare to be cut 90 percent -US health agency Ruby Khatun Khatun1 Sept 2017 9:27 AM ISTWASHINGTON: The U.S. Centers for Medicare and Medicaid Services said on Thursday it plans to spend $10 million on advertising for the upcoming...
Zydus Cadila receives final approval from USFDA for Aspirin and extended release Dipyridamole capsules Ruby Khatun Khatun31 Aug 2017 11:00 AM ISTMumbai: Pharma major, Zydus Cadila said that company received final approval from the US Food and Drug Administration (USFDA) to market Aspirin and...
US clears first LIVING DRUG, developed by Novartis for leukemia treatment, cost- 475,000 dollar Ruby Khatun Khatun31 Aug 2017 11:00 AM ISTOpening a new era in cancer care, the Food and Drug Administration on Wednesday approved the first treatment that genetically engineers patients’ own...
AstraZeneca strikes 400 million dollar Parkinsons drug deal with Takeda Ruby Khatun Khatun31 Aug 2017 10:30 AM ISTLONDON: AstraZeneca is to receive up to $400 million from Takeda Pharmaceutical after striking a deal for the Japanese company to co-develop an...
FDA steps up scrutiny of stem cell therapies Ruby Khatun Khatun31 Aug 2017 10:00 AM ISTThe U.S. Food and Drug Administration (FDA) is stepping up efforts to better regulate an emerging field of medicine that holds significant promise for...
Merck cholesterol drug cuts heart risk only 9 percent, future unclear Ruby Khatun Khatun31 Aug 2017 9:30 AM ISTA large study of a new type of cholesterol medicine from Merck & Co Inc found it cut the risk of heart attack and death by a modest 9 percent...
Zydus Cadila gets EIR from USFDA for Pharma SEZ plant at Ahmedabad savita thakur thakur30 Aug 2017 12:35 PM ISTNEW DELHI: Drug firm Zydus Cadila said it has received establishment inspection report from the US health regulator for its manufacturing facility at...
